Peripherally Inserted Central Catheter (PICC) Global Market Report 2024

The peripherally inserted central catheter (PICC) market size has grown strongly in recent years. It will grow from $1.01 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.61%. The historic growth can be attributed to a shift towards outpatient care, an aging population, reduced healthcare costs, improved patient comfort and safety, and the expansion of interventional radiology.

The peripherally inserted central catheter (PICC) market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2028 at a compound annual growth rate (CAGR) of 5.17%. The anticipated growth in the forecast period is driven by several factors, including the expansion of interventional radiology practices, an increased focus on infection prevention and control measures, rising healthcare expenditure globally, and the implementation of patient-centered care initiatives. Major trends expected during this period include advancements in technology, the adoption of personalized medicine approaches, a shift towards minimally invasive procedures, the integration of digital health technologies into medical practices, and the emphasis on regulatory compliance and standardization within the healthcare industry.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the peripherally inserted central catheter (PICC) market in the forthcoming years. Chronic diseases encompass long-term health conditions that persist over an extended period and often progress slowly, including cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases. PICCs are instrumental in managing chronic conditions by providing long-term intravenous access for administering drugs, fluids, parenteral nutrition, and conducting blood draws. For example, as reported by the National Library of Medicine in January 2023, the projected number of individuals aged 50 years and older with one or more chronic illnesses is expected to increase by 99.5% in the United States, reaching 142.66 million by 2050, up from 71.522 million in 2020. Consequently, the growing prevalence of chronic diseases is fueling the demand for peripherally inserted central catheters (PICCs) and driving market growth.

Major companies in the peripherally inserted central catheter (PICC) market are concentrating on innovative technologies, such as peripherally inserted central catheter insertion devices, to enhance customer experience with advanced features. These devices are specialized medical instruments designed to facilitate the placement of PICCs into peripheral veins, typically in the arm, and guide them to larger veins near the heart. For instance, in May 2023, Teleflex Incorporated, a US-based medical device company, introduced two new insertion devices such as the Arrow VPS Rhythm DLX Device and the NaviCurve Stylet. The VPS Rhythm DLX Device utilizes cardiac electrical activity to provide real-time catheter tip position information and offers an optional integrated ultrasonography feature with a catheter-to-vessel ratio tool for consistent vessel measuring. When used with the Arrow PICC equipped with the NaviCurve Stylet, this device introduces new tip navigation technology. The VPS Rhythm DLX Device, featuring TipTracker Technology, eliminates the need for confirmatory x-rays, enabling physicians to perform smooth ultrasound vascular evaluation, peripherally inserted central catheter navigation, and final tip verification in the bottom third of the superior vena cava.

In September 2022, B. Braun Medical Inc., a US-based company known for its expertise in smart infusion treatment and the development of safe, effective medicinal products, completed the acquisition of the Clik-FIX catheter securement device line from Starboard Medical Inc. The financial details of the transaction were not disclosed. This strategic acquisition bolsters B. Braun's presence in the peripheral intravenous (PIV) therapy market and aligns with its commitment to enhancing patient experience and outcomes. Starboard Medical, Inc., based in the US, specializes in manufacturing medical equipment, including peripherally inserted central catheter (PICC) devices.

Major companies operating in the peripherally inserted central catheter (picc) market report are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Medical Ltd, Teleflex Incorporated, ICU Medical Inc., Cook Medical, AngioDynamics, Argon Medical, PFM Medical Inc., Poly Medicure Ltd., Kimal Plc, Utah Medical Products Inc., Martech Medical Products, NeoMedical, Medical Components Inc, DeltaMed Solutions Inc., Access Vascular Inc., Medi-Tech Devices, Footprint Medical Incorporated, Biowy Corporation, Husk Medical B.V., Medcomp, Vygon Ltd, Haolang Technology (Foshan) Limited Co. Ltd.

North America was the largest region in the peripherally inserted central catheter (PICC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripherally inserted central catheter (picc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripherally inserted central catheter (picc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A peripherally inserted central catheter (PICC) is a slender, flexible tube inserted into a peripheral vein, typically in the arm, and guided until its tip reaches a larger vein near the heart known as the superior vena cava. This device is commonly employed in healthcare settings to facilitate long-term access to intravenous (IV) therapies, including chemotherapy, antibiotics, nutrition, and other medications.

The primary types of peripherally inserted central catheters (PICCs) include power-injectable and non-power-injectable variants. Power-injectable PICCs enable the rapid infusion of fluids or medications, particularly beneficial for critically ill patients. They are further classified based on lumen type into single, double, and triple-lumen configurations, along with specialized kits such as tip-placement kits and conventional kits. End-users of PICCs encompass hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

The peripherally inserted central catheters (PICC) research report is one of a series of new reports that provides peripherally inserted central catheters (PICC) market statistics, including the peripherally inserted central catheters (PICC) industry's global market size, regional shares, competitors with an Peripherally inserted central catheters (PICC) market share, detailed peripherally inserted central catheters (PICC) market segments, market trends and opportunities, and any further data you may need to thrive in the peripherally inserted central catheters (PICC) industry. This peripherally inserted central catheters (PICC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The peripherally inserted central catheter (PICC) market consists of sales of antimicrobial-coated peripherally inserted central catheters, ultrasound-guided peripherally inserted central catheters, radiopaque peripherally inserted central catheters, and MRI-compatible peripherally inserted central catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.